LCEIX | RMFCX | LCEIX / RMFCX | |
Total Expense Ratio | 0.71 | 0.91 | 78% |
Annual Report Gross Expense Ratio | 0.71 | 0.91 | 78% |
Fund Existence | 20 years | 23 years | - |
Gain YTD | 11.464 | 13.689 | 84% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 250 | 400% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 10.6B | 111B | 10% |
Annual Yield % from dividends | 1.30 | 1.20 | 108% |
Returns for 1 year | -0.60 | 4.96 | -12% |
Returns for 3 years | 14.01 | 38.79 | 36% |
Returns for 5 years | 15.70 | 57.10 | 27% |
Returns for 10 years | 27.11 | 91.18 | 30% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
RWO | 45.85 | 0.34 | +0.75% |
SPDR® Dow Jones® Global Real Estate ETF | |||
PJP | 94.07 | 0.64 | +0.68% |
Invesco Pharmaceuticals ETF | |||
GLOW | 30.25 | 0.14 | +0.45% |
VictoryShares WestEnd Global Equity ETF | |||
AVUQ | 59.24 | 0.23 | +0.40% |
Avantis U.S. Quality ETF | |||
GAA | 31.61 | -0.02 | -0.06% |
Cambria Global Asset Allocation ETF |